Optimal cultivation of Chlamydia requires testing of serum on individual species

• Main Authors: Malhar Desai, Huirong Zhang, Huizhou Fan
• Format: Article
• Language: English
• Published: BMC 2020-01-01
• Series: BMC Research Notes
• Subjects: Chlamydia trachomatis; Chlamydia muridarum; Fetal bovine serum; Serum test
• Online Access: https://doi.org/10.1186/s13104-020-4893-9

Abstract Objective This report is a side product of experiments aimed at identifying serum for culturing obligate intracellular bacteria Chlamydia trachomatis and C. muridarum in mouse fibroblast L929 cells. Results Of five commercial serum samples tested, two showed optimal efficiencies at supporting growth of the human pathogen Chlamydia trachomatis as control fetal bovine serum, whereas two showed modest ~ 40% inhibitions in progeny production, and the remaining one showed a 20% inhibition. Three of the six sera poorly supported growth of the murine pathogen Chlamydia muridarum, resulting in 73–90% reduction in progeny formation. Most significantly, the one with the strongest (90%) C. muridarum inhibition activity showed optimal C. trachomatis-supporting efficiency. These findings indicate that in laboratories that study multiple Chlamydia species, serum samples should be prescreened on a species basis. Considering Chlamydial biology and epidemiology, it may even be necessary to perform serum tests on a serovar- or strain-basis for studying some animal chlamydiae.